NCT00574522

Energy Specific Far Infrared Radiation Treatment for AIDS

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for HIV/AIDS

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 3 (actual)
• Sponsor: GAAD Medical Research Institute Inc. · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The investigators are proposing that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of killer cells to fight and destroy the human immunodeficiency virus.

Detailed description

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS or Aids) is a collection of symptoms and infections resulting from the specific damage to the immune system caused by the human immunodeficiency virus (HIV) in humans. The late stage of the condition leaves individuals prone to opportunistic infections and tumors. Although treatments for AIDS and HIV exist to slow the virus' progression, there is no known cure. The investigators are postulating that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of CD4+ T cells and other killer cells to fight and destroy the human immunodeficiency virus. The primary end point is to determine the therapeutic effects of far infrared radiation (5μm to 20μm wavelength) on HIV/AIDS.

Conditions

• HIV Infections

Interventions

Type	Name	Description
RADIATION	Far infrared	Far infrared radiation with the wavelength between 5μm and 20μm for 30 to 40 minutes per session.

Timeline

• Start date: 2008-02-01
• Primary completion: 2009-08-01
• Completion: 2009-11-01
• First posted: 2007-12-17
• Last updated: 2009-08-17

Locations

1 site across 1 country: Canada